Carisoprodol And Aspirin
Product Images NDC 21695-570

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carisoprodol And Aspirin (NDC 21695-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Structural Formula (E4c5e195 E3f1 487a Accd C2c6fbbd7837 01)

Chemical structure diagram of the active ingredient carisoprodol. The structure shows molecular connectivity including amide and carbamate groups with associated carbon and nitrogen atoms.*

FDA Label Image

Image Of Aspirin Formula (E4c5e195 E3f1 487a Accd C2c6fbbd7837 02)

Chemical structure diagram showing a benzene ring with a carboxyl group (COOH) and a methyl ester group (OOCH3) attached, representing the chemical structure of one of the active ingredients associated with Carisoprodol and Aspirin.*

FDA Label Image

Carisoprodol 20mg/aspirin 325mg (E4c5e195 E3f1 487a Accd C2c6fbbd7837 03)

Carisoprodol 200 mg and Aspirin 325 mg tablets label from Rebel Distributors Corp. The label indicates a count of 30 tablets and shows product identification information including NDC 21695-570-30. It is marked RX Only and includes storage instructions at controlled room temperature. The manufacturer is listed as Sandoz Inc., Princeton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.